Largest Insider Trades of the Week

Last week's insider trades above $5 million

Author's Avatar
Jan 16, 2017
Article's Main Image

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$5,0000,000+” and the duration to “January 2016” and All Insider Sales to “$5,000,000+.”

According to the above filters, the following are trades from company insiders this week.

Bruce R. Berkowitz, 10% owner of Seritage Growth Properties Class A. (SRG, Financial), bought 140,600 shares for $39.52 per share on Jan 13. Since then, the stock price has declined by 0.3% to $39.80.

The company has institutional ownership of 64.18% and insider ownership of 1.01%. It is a self-administered, self-managed REIT engaged in the real estate property business through its investment in Seritage Growth Properties L.P.

Over the last 12 months, the price of the stock has risen by 5% and is now trading with a price-book (P/B) ratio of 2.68. The price is 3.55% below its 52-week high and 9.70% above its 52-week low

Sanofi, 10% owner of Regeneron Pharmaceuticals Inc. (REGN, Financial), bought 87,298 shares of the company for $369.71 per share on Jan 11. Since then, the stock price has fallen 0.4% to $368.16.

The company has institutional ownership of 91.88% and insider ownership of 1.35%. It is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.

Over the last 12 months, the stock price has risen 18% and is now trading with a P/B ratio of 8.64. The price is 24.33% below its 52-week high and 13.16% above its 52-week low.

Baker Bros. Advisors LP, 10% owner of Aquinox Pharmaceuticals Inc. (AQXP, Financial), bought 398,062 shares of the company for $17.18 per share on Jan 9. Since then, the stock price has risen 4.3% to $17.92.

The company has institutional ownership of 91.54% and insider ownership of 0.43%. Aquinox is a clinical-stage pharmaceutical company engaged in discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.

Over the last 12 months, the stock price has risen 94% and is now trading with a P/B ratio of 2.70. The price is 6.28% below its 52-week high and 198.17% above its 52-week low.

Matthew Strobeck, director, John Patience, director and 10% owner, and Jack W. Schuller, director and 10% owner of Accelerate Diagnostics Inc. (AXDX, Financial), bought 400,136 shares of the company for $19 per share on Jan 9. Since then, the stock price has risen 19.2% to $22.65.

The company has institutional ownership of 36.56% and insider ownership of 5.98%. It is an in vitro diagnostics company engaged in developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.

Over the last 12 months, the price of the stock has risen 30% and is now trading with a P/B ratio of 12.7. The price is 20.53% below its 52-week high and 120.12% above its 52-week low.

Most important sales of the week

Sidney B. Deboer, director of Lithia Motors Inc. Class AÂ (LAD, Financial), sold 52,800 shares of the company for $101.56 per share on Jan 13. Since then, the stock price has decreased 0.2% to $101.33.

The company has institutional ownership of 96.02% and insider ownership of 3.57%. It is an operator of automotive franchises and a retailer of new and used vehicles and related services.

Over the last 12 months, the stock price has risen 35% and is now trading with a P/B ratio of 2.94. The price is 2.98% below its 52-week high and 47.50% above its 52-week low.

Bruce Bainum, 10% owner of Choice Hotels International Inc. (CHH, Financial), sold 75,000 shares of the company for $54.38 per share on Jan 13. Since then, the stock price has not changed.

The company has institutional ownership of 50.04% and insider ownership of 3.80%. It operates in two reportable segments that encompass its hotel franchising business and its SkyTouch Technology ("SkyTouch") division.

Over the last 12 months, the stock price has risen 30% and is now trading with a price-earnings (P/E) ratio of 22.86. The price is 5.19% below its 52-week high and 33.40% above its 52-week low.

Michael D. Perone, chief marketing officer, executive vice president and 10% owner of Barracuda Networks Inc. (CUDA, Financial), sold 1,311,350 shares of the company for $24.54 per share on Jan 12. Since then, the stock price has fallen 1.3% to $24.21.

The company has institutional ownership of 56.60% and insider ownership of 16.98%. It designs and delivers security and storage solutions. It offers cloud-connected solutions that help customers address security threats, improve network performance and protect and store data.

Over the last 12 months, the stock price has increased 140% and is now trading with a P/E ratio of 127.42. The price is 9.29% below its 52-week high and 156.46% above its 52-week low.

David C. Drummond, senior vice president of corporate development of Alphabet Inc. Class CÂ (GOOG, Financial), sold 2,000 shares of the company for $817.76 per share on Jan 12. Since then, the price of the stock has fallen 1.2% to $807.88.

The company has institutional ownership of 34.92% and insider ownership of 0.36%. Through its subsidiary, Google Inc., it is engaged in improving the ways people connect with information and products, including Search, Android, YouTube, Apps, Maps and Ads. It also produces internet-connected home devices and provides internet services.

Over the last 12 months, the stock price has risen 15% and is now trading with a P/B ratio of 4.27. The price is 1.08% below its 52-week high and 21.84% above its 52-week low.

Disclosure: I do not own any shares of any stocks mentioned in this article.

Start a free 7-day trial of Premium Membership to GuruFocus.